Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  4, 194 - 200 (1998)
doi:10.1038/nm0298-194

Adenovirus-mediated gene transfer into cold-preserved liver allografts: Survival pattern and unresponsiveness following transduction with CTLA4Ig

Kim M. Olthoff1, 5, Thomas A. Judge2, Andrew E. Gelman1, Xiu Da Shen1, Wayne W. Hancock4, Laurence A. Turka3 & Abraham Shaked1

  1Department of Surgery, University of Pennsylvania, 4 Silverstein, 3400 Spruce St. Philadelphia, Pennsylvania 19104, USA

  2Department of Medicine, Division of Gastroenterology, University of Pennsylvania, 3 Dulles, 3400 Spruce St. Philadelphia, Pennsylvania 19104, USA

  3Department of Pathology, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts, 02115 USA

  4Department of Medicine, University of Pennsylvania, 901 BRB-1, 422 Curie Boulevard, Philadelphia, Pennsylvania 19104, USA

  5e-mail, kolthoff@mail.med.upenn.edu

The immune response of liver transplant recipients was modulated via adenovirus-mediated transduction of the cold-preserved liver with sequences encoding CTLA4lg. Transplanted allografts demonstrated rapid transient local expression and recombinant protein production shortly after revascularization, resulting in intact liver function, indefinite survival of the recipient, and the development of donor-specific unresponsiveness. Lymphocytic infiltration of the graft was mainly of the T helper 2 (Th2) subset and was not associated with injury to primary cellular targets of the alloimmune response. These findings demonstrate a successful outcome of a feasible and potentially clinically relevant system of gene delivery of sequences encoding proteins capable of inhibiting the alloimmune response.

REFERENCES
  1. Grusby, M.J. et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl. Acad. Sci. USA 90, 3913−3917 (1993). | PubMed  | ChemPort |
  2. Auchincloss, J. Jr., et al. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 90, 3373−3377 (1993). | PubMed  | ChemPort |
  3. Cozzi, D. & White, D.J. The generation of transgenic pigs as potential organ donors for humans. Nature Med. 1, 964−966 (1995). | Article | PubMed  | ISI | ChemPort |
  4. Byrne, G.W. et al. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage. Transplantation 63,149−155 (1997). | PubMed  | ChemPort |
  5. Snaked, A. et al. Adenovirus-mediated gene transfer in the transplant setting II: Successful expression of transferred cDNA in syngeneic liver grafts. Transplantation 57, 1508−1511 (1994). | PubMed  | ISI | ChemPort |
  6. Drazan, K.E., et al. In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116, 197−204 (1994). | ISI |
  7. Drazan, K.E., Chen, X.D., Busuttil, R.W., Csete, M. & Shaked, A. Gene transfer in the transplant setting III: Variables affecting recombinant gene expression in liver grafts. Transplantation 59, 670−673 (1995). | PubMed  | ISI | ChemPort |
  8. Drazan, K.E. et al. Hepatic liver function is preserved after adenoviral-mediated gene transfer. J.Surg.Res. 59, 299−304 (1995). | Article | ChemPort |
  9. Lin, H. et al. Long-term acceptance of major histocompatibility complex mismatched cardiac allograft induced by CTLA4lg plus donor-specific transfusion. J. Exp. Med. 178, 1801−1806 (1993). | Article | ISI |
  10. Baliga, P. et al. CTLA4lg prolongs allograft survival while suppressing cell-mediated immunity. Transplantation 58, 1082−1090 (1994). | ISI |
  11. Lenschow, D.J. et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257, 789−792 (1992). | ISI |
  12. Wang, J. jiano, S., Wolff, J.A., & Knechtle, S.J. Gene transfer and expression in rat cardiac transplant. Transplantation 53, 703−705 (1992). | PubMed  | ISI | ChemPort |
  13. Shaked, A. et al. Retroviral-mediated gene transfer into rat experimental liver transplant. Transplantation 57, 32−32 (1994). | PubMed  | ISI | ChemPort |
  14. Csete, M.E. et al. Adenovirus-mediated gene transfer in the transplant setting. I. Conditions for expression of transferred gene in cold preserved hepatocytes. Transplantation 57, 1502−1507 (1994). | ISI |
  15. Tripathy, S.K., Black, H.B., Goldwasser, E. & Leiden, J.M. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545−550 (1996). | Article | PubMed  | ISI | ChemPort |
  16. Yang, Y., Su, Q. & Wilson, J.M. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70, 7209−7212(1996). | PubMed  | ISI | ChemPort |
  17. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C. & Wilson, J.M. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3,137−144 (1996). | PubMed  | ISI | ChemPort |
  18. Linsley, P.S. et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 257, 792−795 (1992). | ISI |
  19. Sayegh, M.H., et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Thi cytokines but spares Th2. J. Exp. Med. 181, 1869−1874 (1995).
  20. Judge, T.A., et al. The in vivo mechanisms of action of CTLA4Ig. J. Immunol. 156, 2294−2299 (1996). | ISI |
  21. Kamada, N. & Calne, R.Y. Orthotopic liver transplantation in the rat: Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 28, 47 (1979). | PubMed  | ChemPort |
  22. Lin, H., lammattoni, M.D., Modblum, J.R., & Boiling, S.F. Experimental hetero-topic heart transplantation without ischemia or reperfusion. J. Heart Transplant.9,720(1990). | PubMed  |
  23. Hirt, J.M.B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365−369 (1967). | ISI |
  24. Graham, F.L. & van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52 2(2)456−467 (1973). | Article | PubMed  | ChemPort |
  25. Hancock, W.W. et al. Costimulatory function and expression of CD40-ligand, CD80 and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. USA 93, 13967−13972 (1996). | Article | PubMed  | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1998 Nature Publishing Group | Privacy policy